BA-434

N/A

Report date: 2023/12/18 18:09:32
NME

Base Information

Drug NameBA-434
Drug Alias NameN/A
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionRNA interferencePhosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN inhibitors
TargetsPhosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN
Therapy Area/IndicationsSpinal Cord Injuries
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBioaxone Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesBioaxone Biosciences Inc
Inactive CompaniesN/A
Active IndicationsSpinal Cord Injuries
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A